{"schema":"hottub-news/prospects/v1","item":{"id":"n_fmyfmkphd36lp6c2uhsa","title":"FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata","title_en":null,"url":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata","outlet":"Utusan Malaysia","published":"2026-11-11T01:30:00Z","sponsored":false,"page":"https://hottub.news/articles/n_fmyfmkphd36lp6c2uhsa"},"prospects":[{"name":"ISZ YUSLIZA","kind":"person","role":"reporter","company":"Utusan Malaysia","website":"https://utusan.com.my/","source":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata","note":"Wrote: FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata","reason":"Reporter at Utusan Malaysia; wrote “FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata” on 2026-11-11","group":"Reporters","add_url":"https://crm.joinhottub.com/relationships/add#name=ISZ%20YUSLIZA&company=Utusan%20Malaysia&website=https%3A%2F%2Futusan.com.my%2F&source=https%3A%2F%2Fwww.utusan.com.my%2Fluar-negara%2F2026%2F11%2Ffda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata&note=Wrote%3A%20FDA%20arah%20pengeluar%20ubat%20kurus%20GLP-1%20dedah%20risiko%20masalah%20mata","propose":{"name":"ISZ YUSLIZA","kind":"person","reason":"Reporter at Utusan Malaysia; wrote “FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata” on 2026-11-11","requestId":"news:n_fmyfmkphd36lp6c2uhsa:Reporter:595fb180:0c40b29c","company":"Utusan Malaysia","website":"https://utusan.com.my/","sourceUrl":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata"}},{"name":"Utusan Malaysia","kind":"organization","role":"outlet","website":"https://utusan.com.my/","entity":"wikidata:Q863351","source":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata","note":"Published: FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata (2026-11-11)","reason":"Published “FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata” on 2026-11-11","group":"Outlet","add_url":"https://crm.joinhottub.com/relationships/add#name=Utusan%20Malaysia&kind=organization&website=https%3A%2F%2Futusan.com.my%2F&source=https%3A%2F%2Fwww.utusan.com.my%2Fluar-negara%2F2026%2F11%2Ffda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata&entity=wikidata%3AQ863351&note=Published%3A%20FDA%20arah%20pengeluar%20ubat%20kurus%20GLP-1%20dedah%20risiko%20masalah%20mata%20%282026-11-11%29","propose":{"name":"Utusan Malaysia","kind":"organization","reason":"Published “FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata” on 2026-11-11","requestId":"news:n_fmyfmkphd36lp6c2uhsa:wikidata:Q863351:e3e7b651","website":"https://utusan.com.my/","sourceUrl":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata","entity":"wikidata:Q863351"}}],"someone_else":{"source":"https://www.utusan.com.my/luar-negara/2026/11/fda-arah-pengeluar-ubat-kurus-glp-1-dedah-risiko-masalah-mata","note":"In the news: FDA arah pengeluar ubat kurus GLP-1 dedah risiko masalah mata (Utusan Malaysia, 2026-11-11)"},"crm":{"name":"CRM by Hottub","add":"Open add_url in a browser: CRM by Hottub's add form, filled in. Nothing is saved until the person presses Add.","mcp":"https://crm.joinhottub.com/api/crm/mcp","tool":"propose_relationship","propose":"If you're connected to CRM by Hottub's MCP server with proposal access, call propose_relationship with `propose` as its arguments. An owner approves it before anything is added. Keep the arguments as given: retries reuse requestId."}}